BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 31931403)

  • 21. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of
    Bi S; Yan S; Chen Z; Cui B; Shan Y; Yang H; Qi Z; Zhao Z; Han Y; Lu J
    EJNMMI Res; 2024 Jan; 14(1):9. PubMed ID: 38270821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrovascular reactivity measurements using simultaneous
    Zhao MY; Fan AP; Chen DY; Sokolska MJ; Guo J; Ishii Y; Shin DD; Khalighi MM; Holley D; Halbert K; Otte A; Williams B; Rostami T; Park JH; Shen B; Zaharchuk G
    Neuroimage; 2021 Jun; 233():117955. PubMed ID: 33716155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
    Hatashita S; Yamasaki H
    PLoS One; 2013; 8(6):e66877. PubMed ID: 23799136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
    Richter N; Nellessen N; Dronse J; Dillen K; Jacobs HIL; Langen KJ; Dietlein M; Kracht L; Neumaier B; Fink GR; Kukolja J; Onur OA
    Neuroimage Clin; 2019; 24():101978. PubMed ID: 31422337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring ASL perfusion MRI as a substitutive modality for 18F-FDG PET in determining the laterality of mesial temporal lobe epilepsy.
    Rahimzadeh H; Kamkar H; Ghafarian P; Hoseini-Tabatabaei N; Mohammadi-Mobarakeh N; Mehvari-Habibabadi J; Hashemi-Fesharaki SS; Nazem-Zadeh MR
    Neurol Sci; 2024 May; 45(5):2223-2243. PubMed ID: 37994963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.
    Atay LO; Saka E; Akdemir UO; Yetim E; Balcı E; Arsava EM; Topcuoglu MA
    Curr Alzheimer Res; 2023; 20(7):481-495. PubMed ID: 38050727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
    Altomare D; Ferrari C; Caroli A; Galluzzi S; Prestia A; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen CE; Wall A; Carter SF; Schöll M; Choo ILH; Grimmer T; Redolfi A; Nordberg A; Scheltens P; Drzezga A; Frisoni GB;
    J Neurol; 2019 Oct; 266(10):2535-2545. PubMed ID: 31267207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?
    Teipel S; Grothe MJ;
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):526-36. PubMed ID: 26555082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study.
    Kaneta T; Katsuse O; Hirano T; Ogawa M; Shihikura-Hino A; Yoshida K; Odawara T; Hirayasu Y; Inoue T
    BMC Neurol; 2017 May; 17(1):91. PubMed ID: 28506213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.
    Yan S; Zheng C; Cui B; Qi Z; Zhao Z; An Y; Qiao L; Han Y; Zhou Y; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2440-2452. PubMed ID: 32157432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
    Yan L; Liu CY; Wong KP; Huang SC; Mack WJ; Jann K; Coppola G; Ringman JM; Wang DJJ
    Neuroimage Clin; 2018; 17():751-760. PubMed ID: 29527482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Task-enhanced arterial spin labeled perfusion MRI predicts longitudinal neurodegeneration in mild cognitive impairment.
    Xie L; Das SR; Pilania A; Daffner M; Stockbower GE; Dolui S; Yushkevich PA; Detre JA; Wolk DA
    Hippocampus; 2019 Jan; 29(1):26-36. PubMed ID: 30207006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.